Literature DB >> 18667584

Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complex.

S Josefin Bartholdson1, Alan R Brown, Ben R Mewburn, David J Clarke, Stephen C Fry, Dominic J Campopiano, John R W Govan.   

Abstract

The species that presently constitute the Burkholderia cepacia complex (Bcc) have multiple roles; they include soil and water saprophytes, bioremediators, and plant, animal and human pathogens. Since the first description of pathogenicity in the Bcc was based on sour skin rot of onion bulbs, this study returned to this plant host to investigate the onion-associated phenotype of the Bcc. Many Bcc isolates, which were previously considered to be non-mucoid, produced copious amounts of exopolysaccharide (EPS) when onion tissue was provided as the sole nutrient. EPS production was not species-specific, was observed in isolates from both clinical and environmental sources, and did not correlate with the ability to cause maceration of onion tissue. Chemical analysis suggested that the onion components responsible for EPS induction were primarily the carbohydrates sucrose, fructose and fructans. Additional sugars were investigated, and all alcohol sugars tested were able to induce EPS production, in particular mannitol and glucitol. To investigate the molecular basis for EPS biosynthesis, we focused on the highly conserved bce gene cluster thought to be involved in cepacian biosynthesis. We demonstrated induction of the bce gene cluster by mannitol, and found a clear correlation between the inability of representatives of the Burkholderia cenocepacia ET12 lineage to produce EPS and the presence of an 11 bp deletion within the bceB gene, which encodes a glycosyltransferase. Insertional inactivation of bceB in Burkholderia ambifaria AMMD results in loss of EPS production on sugar alcohol media. These novel and surprising insights into EPS biosynthesis highlight the metabolic potential of the Bcc and show that a potential virulence factor may not be detected by routine laboratory culture. Our results also highlight a potential hazard in the use of inhaled mannitol as an osmolyte to improve mucociliary clearance in individuals with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667584     DOI: 10.1099/mic.0.2008/019216-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  The OmpR Regulator of Burkholderia multivorans Controls Mucoid-to-Nonmucoid Transition and Other Cell Envelope Properties Associated with Persistence in the Cystic Fibrosis Lung.

Authors:  Inês N Silva; Filipa D Pessoa; Marcelo J Ramires; Mário R Santos; Jörg D Becker; Vaughn S Cooper; Leonilde M Moreira
Journal:  J Bacteriol       Date:  2018-08-10       Impact factor: 3.490

2.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

3.  Distribution of cepacian biosynthesis genes among environmental and clinical Burkholderia strains and role of cepacian exopolysaccharide in resistance to stress conditions.

Authors:  Ana S Ferreira; Jorge H Leitão; Inês N Silva; Pedro F Pinheiro; Sílvia A Sousa; Christian G Ramos; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

4.  Tyrosine Phosphorylation and Dephosphorylation in Burkholderia cenocepacia Affect Biofilm Formation, Growth under Nutritional Deprivation, and Pathogenicity.

Authors:  Angel Andrade; Faviola Tavares-Carreón; Maryam Khodai-Kalaki; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2015-11-20       Impact factor: 4.792

5.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

6.  Emerging treatments in cystic fibrosis.

Authors:  Andrew M Jones; Jennifer M Helm
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

7.  Pectin Enhances Bio-Control Efficacy by Inducing Colonization and Secretion of Secondary Metabolites by Bacillus amyloliquefaciens SQY 162 in the Rhizosphere of Tobacco.

Authors:  Kai Wu; Zhiying Fang; Rong Guo; Bin Pan; Wen Shi; Saifei Yuan; Huilin Guan; Ming Gong; Biao Shen; Qirong Shen
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

Review 8.  Maintenance and assessment of cell viability in formulation of non-sporulating bacterial inoculants.

Authors:  Teresa Berninger; Óscar González López; Ana Bejarano; Claudia Preininger; Angela Sessitsch
Journal:  Microb Biotechnol       Date:  2017-12-04       Impact factor: 5.813

Review 9.  Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments.

Authors:  Ana S Ferreira; Inês N Silva; Vítor H Oliveira; Raquel Cunha; Leonilde M Moreira
Journal:  Front Cell Infect Microbiol       Date:  2011-12-15       Impact factor: 5.293

10.  Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.

Authors:  Ruth R Miller; Trevor J Hird; Patrick Tang; James E A Zlosnik
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.